Date：29 July (Friday) 10:40 – 12:10 (GMT+8)
Venue：701EF, TaiNEX2, Taipei + Online event platform
Highly pertinent to the conference theme Connecting the Asian Value Chain, the regions’ Contract Development and Manufacturing Organization (CDMO) resources are essential to the growing regional and international demand for biomedical products. Driving this is the rising popularity of biologics as a treatment option, the demand for pandemic vaccines, the increasing number of patients with chronic diseases, and growing overall pharmaceutical demand. With biologics being more complex than small molecule drugs, the number of elaborate bio-manufacturing facilities is growing rapidly. With an annual growth rate at over 6 percent, market research firm DelveInsight pegged the market to be worth US$143 billion by 2027, with the Asia-Pacific region expected to dominate the global CDMO market at least up to that time. Join us in this session as key CDMO industry leaders from Asia and around the world discuss industry trends, global market opportunities and partnership strategies.